Latest Insider Transactions at Castlight Health, Inc. (CSLT)
This section provides a real-time view of insider transactions for Castlight Health, Inc. (CSLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CASTLIGHT HEALTH, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CASTLIGHT HEALTH, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,398
-9.04%
|
$8,398
$1.89 P/Share
|
Feb 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
59,615
-4.27%
|
$59,615
$1.89 P/Share
|
Feb 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,419
+2.51%
|
-
|
Feb 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,332
+4.3%
|
-
|
Feb 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
156,292
+1.89%
|
-
|
Jan 26
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
40,000
-10.78%
|
$80,000
$2.0 P/Share
|
Jan 07
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
1,613
-0.43%
|
$1,613
$1.45 P/Share
|
Dec 31
2020
|
Maeve O'Meara Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,511
-1.31%
|
$16,511
$1.3 P/Share
|
Dec 31
2020
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,300
+2.58%
|
-
|
Dec 28
2020
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
30,000
-7.45%
|
$30,000
$1.5 P/Share
|
Nov 20
2020
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
7,800
-1.9%
|
$7,800
$1.25 P/Share
|
Nov 19
2020
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
29,319
-6.67%
|
$29,319
$1.22 P/Share
|
Nov 17
2020
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
48,844
-18.49%
|
$48,844
$1.14 P/Share
|
Nov 17
2020
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
6,929
-8.61%
|
$6,929
$1.14 P/Share
|
Nov 17
2020
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
577,907
-32.07%
|
$577,907
$1.14 P/Share
|
Nov 16
2020
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
136,254
+7.97%
|
-
|
Nov 16
2020
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,333
+5.0%
|
-
|
Nov 16
2020
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,283,528
+11.25%
|
-
|
Oct 07
2020
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
1,612
-0.37%
|
$1,612
$1.06 P/Share
|
Jun 20
2018
|
Maverick Capital LTD > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
32,183
+1.78%
|
-
|